Fusion Genes Altered in Adult Malignant Gliomas

Malignant gliomas are highly heterogeneous brain tumors in molecular genetic background. Despite the many recent advances in the understanding of this disease, patients with adult high-grade gliomas retain a notoriously poor prognosis. Fusions involving oncogenes have been reported in gliomas and ma...

Full description

Bibliographic Details
Main Authors: Gan You, Xing Fan, Huimin Hu, Tao Jiang, Clark C. Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2021.715206/full
id doaj-f8fa32b7c921434984fbb3d8f65d0c34
record_format Article
spelling doaj-f8fa32b7c921434984fbb3d8f65d0c342021-10-04T05:29:03ZengFrontiers Media S.A.Frontiers in Neurology1664-22952021-10-011210.3389/fneur.2021.715206715206Fusion Genes Altered in Adult Malignant GliomasGan You0Gan You1Xing Fan2Huimin Hu3Tao Jiang4Tao Jiang5Clark C. Chen6Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurophysiology, Beijing Neurosurgical Institute, Beijing, ChinaDepartment of Neurophysiology, Beijing Neurosurgical Institute, Beijing, ChinaDepartment of Molecular Pathology, Beijing Neurosurgical Institute, Beijing, ChinaDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Molecular Pathology, Beijing Neurosurgical Institute, Beijing, ChinaDepartment of Neurosurgery, University of Minnesota, Minneapolis, MN, United StatesMalignant gliomas are highly heterogeneous brain tumors in molecular genetic background. Despite the many recent advances in the understanding of this disease, patients with adult high-grade gliomas retain a notoriously poor prognosis. Fusions involving oncogenes have been reported in gliomas and may serve as novel therapeutic targets to date. Understanding the gene fusions and how they regulate oncogenesis and malignant progression will contribute to explore new approaches for personalized treatment. By now, studies on gene fusions in gliomas remain limited. However, some current clinical trials targeting fusion genes have presented exciting preliminary findings. The aim of this review is to summarize all the reported fusion genes in high-grade gliomas so far, discuss the characterization of some of the most popular gene fusions occurring in malignant gliomas, as well as their function in tumorigenesis, and the underlying clinical implication as therapeutic targets.https://www.frontiersin.org/articles/10.3389/fneur.2021.715206/fullfusion genehigh-grade gliomaglioblastomatargeted therapypersonalized cancer medicine
collection DOAJ
language English
format Article
sources DOAJ
author Gan You
Gan You
Xing Fan
Huimin Hu
Tao Jiang
Tao Jiang
Clark C. Chen
spellingShingle Gan You
Gan You
Xing Fan
Huimin Hu
Tao Jiang
Tao Jiang
Clark C. Chen
Fusion Genes Altered in Adult Malignant Gliomas
Frontiers in Neurology
fusion gene
high-grade glioma
glioblastoma
targeted therapy
personalized cancer medicine
author_facet Gan You
Gan You
Xing Fan
Huimin Hu
Tao Jiang
Tao Jiang
Clark C. Chen
author_sort Gan You
title Fusion Genes Altered in Adult Malignant Gliomas
title_short Fusion Genes Altered in Adult Malignant Gliomas
title_full Fusion Genes Altered in Adult Malignant Gliomas
title_fullStr Fusion Genes Altered in Adult Malignant Gliomas
title_full_unstemmed Fusion Genes Altered in Adult Malignant Gliomas
title_sort fusion genes altered in adult malignant gliomas
publisher Frontiers Media S.A.
series Frontiers in Neurology
issn 1664-2295
publishDate 2021-10-01
description Malignant gliomas are highly heterogeneous brain tumors in molecular genetic background. Despite the many recent advances in the understanding of this disease, patients with adult high-grade gliomas retain a notoriously poor prognosis. Fusions involving oncogenes have been reported in gliomas and may serve as novel therapeutic targets to date. Understanding the gene fusions and how they regulate oncogenesis and malignant progression will contribute to explore new approaches for personalized treatment. By now, studies on gene fusions in gliomas remain limited. However, some current clinical trials targeting fusion genes have presented exciting preliminary findings. The aim of this review is to summarize all the reported fusion genes in high-grade gliomas so far, discuss the characterization of some of the most popular gene fusions occurring in malignant gliomas, as well as their function in tumorigenesis, and the underlying clinical implication as therapeutic targets.
topic fusion gene
high-grade glioma
glioblastoma
targeted therapy
personalized cancer medicine
url https://www.frontiersin.org/articles/10.3389/fneur.2021.715206/full
work_keys_str_mv AT ganyou fusiongenesalteredinadultmalignantgliomas
AT ganyou fusiongenesalteredinadultmalignantgliomas
AT xingfan fusiongenesalteredinadultmalignantgliomas
AT huiminhu fusiongenesalteredinadultmalignantgliomas
AT taojiang fusiongenesalteredinadultmalignantgliomas
AT taojiang fusiongenesalteredinadultmalignantgliomas
AT clarkcchen fusiongenesalteredinadultmalignantgliomas
_version_ 1716844389025710080